Alector, Inc. Accrued Liabilities, Current
Alector, Inc. (ALEC) had Accrued Liabilities, Current of $7.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $7.04M.
- 2026-03-31: Accrued Liabilities, Current $10.93M.
- 2025-12-31: Accrued Liabilities, Current $19.30M.
- 2025-09-30: Accrued Liabilities, Current $18.33M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $7.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $10.93M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $19.30M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $18.33M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $14.21M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $17.32M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $28.89M 10-K · filed 2026-02-25 |
| 2024-09-30 | $25.70M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $23.08M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $19.39M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $30.38M 10-K · filed 2025-02-26 |
| 2023-09-30 | $30.42M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $22.92M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $18.58M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $27.77M 10-K · filed 2024-02-27 |
| 2022-09-30 | $23.23M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $23.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $20.04M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $27.46M 10-K · filed 2023-02-28 |
| 2021-09-30 | $20.59M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $22.10M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $18.97M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $22.54M 10-K · filed 2022-02-24 |
| 2020-09-30 | $27.07M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $15.58M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $16.71M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $18.26M 10-K · filed 2021-02-25 |
| 2019-09-30 | $16.55M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.58M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $8.00M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $8.44M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |